Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK.

MLA

Vin, Harina, et al. “Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK.” Molecular Cancer Therapeutics, vol. 13, no. 1, Jan. 2014, pp. 221–29. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-13-0561.

APA

Vin, H., Ching, G., Ojeda, S. S., Adelmann, C. H., Chitsazzadeh, V., Dwyer, D. W., Ma, H., Ehrenreiter, K., Baccarini, M., Ruggieri, R., Curry, J. L., Ciurea, A. M., Duvic, M., Busaidy, N. L., Tannir, N. M., & Tsai, K. Y. (2014). Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK. Molecular Cancer Therapeutics, 13(1), 221–229. https://doi.org/10.1158/1535-7163.MCT-13-0561

Chicago

Vin, Harina, Grace Ching, Sandra S Ojeda, Charles H Adelmann, Vida Chitsazzadeh, David W Dwyer, Haiching Ma, et al. 2014. “Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK.” Molecular Cancer Therapeutics 13 (1): 221–29. doi:10.1158/1535-7163.MCT-13-0561.